RXO, Inc. (RXO) director discloses RSU grant and 7,745-share acquisition
Rhea-AI Filing Summary
RXO, Inc. reported that one of its directors completed several equity transactions on January 2, 2026. The director acquired 7,745 shares of common stock at a stated price of $0 through the exercise of derivative awards and, after this transaction, directly held 283,161 common shares.
On the same date, the director was granted 14,517 restricted stock units (RSUs), each representing a right to receive either one share of common stock or a cash amount equal to its fair market value. These RSUs are scheduled to vest in full on January 2, 2027, subject to continued service as a director. A prior RSU award covering 7,745 units vested on January 2, 2026, resulting in the corresponding common shares being issued.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did RXO (RXO) report on January 2, 2026?
A director of RXO, Inc. reported acquiring 7,745 shares of common stock at a stated price of $0 through the exercise of derivative awards and updated their holdings accordingly.
How many RXO shares does the reporting director own after the transaction?
Following the reported transaction, the director directly beneficially owns 283,161 shares of RXO common stock, as disclosed in the filing.
What new RSU grant did the RXO director receive?
The director received a grant of 14,517 restricted stock units (RSUs). Each RSU represents a right to receive either one share of RXO common stock or a cash payment equal to its fair market value upon settlement.
When do the newly granted RXO RSUs vest?
The 14,517 RSUs granted to the director are scheduled to vest in full on January 2, 2027, subject to the director’s continued service on RXO’s board.
What happened to the RXO RSUs that vested on January 2, 2026?
A prior award of 7,745 RSUs vested on January 2, 2026. Upon vesting, these RSUs were settled into 7,745 shares of RXO common stock at a stated price of $0.
What does each RXO RSU represent for the reporting director?
Each RSU represents a contingent right to receive, upon settlement, either one share of RXO common stock or a cash payment equal to the fair market value of one share.